Document is current
Any future updates will be listed below
-
Authors
Segireddy, Rameswara R.
Belda, Hugo
Yang, Annie S. P.
Dundas, Kirsten
Knoeckel, Julia
Galaway, Francis
Wood, Laura
Quinkert, Doris
Knuepfer, Ellen
Treeck, Moritz
Wright, Gavin J.
Douglas, Alexander D.
-
Funding
Funding for this research was provided by:
Wellcome Trust (Grant 201477/Z/16/Z, Grant 206194, Grant 206194, Grant 206194, Grant 206194, Grant 206194, Grant 201477/Z/16/Z)
The European Union’s Horizon 2020 research and innovation programme (Under grant agreement No 733273, ‘Optimalvax’, Under grant agreement No 733273, ‘Optimalvax’, Under grant agreement No 733273, ‘Optimalvax’, Under grant agreement No 733273, ‘Optimalvax’, Under grant agreement No 733273, ‘Optimalvax’, Under grant agreement No 733273, ‘Optimalvax’, Under grant agreement No 733273, ‘Optimalvax’)
Cancer Research UK, the UK Medical Research Council, the Wellcome Trust (Core Funding from The Francis Crick Institute, Core Funding from The Francis Crick Institute)
The Dutch Research Council (NOW) talent program veni (VI.Veni.192.171)
Medical Research Council (Doctoral Training award MR/J004111/1)
- License Information
-
More Information
Article History
Received: 7 December 2023
Accepted: 20 March 2024
First Online: 16 May 2024
Declarations
:
: Ethics statement is described in the Methods section.
: Not applicable.
: The authors declare that they have no competing interests.
